Clinical Practice Guidelines FOR THE DIAGNOSIS AND MANAGEMENT OF LYMPHOMA APPROVED BY Clinical Practice Guidelines for the

Council Act 1992. Approval for the guidelines by the NHMRC is granted for a period not exceeding five years, at which date the approval expires. The NHMRC expects that all guidelines will be reviewed no less than once every five years. Readers should check with the Australian Cancer Network for any reviews or updates of these guidelines. Disclaimer This document is a general guide to appropriate practice, to be followed only subject to the clinician’s judgement in each individual case. The guidelines are designed to provide information to assist in decision making and are based on the best information available at the date of compilation (August 2004). Conflict of interest The development of these clinical practice guidelines has been by a non-remunerated working party of the Australian Cancer Network, with further support from The Cancer Council Australia and the Clinical Oncological Society of Australia. Some members of the working party have received sponsorship to attend scientific meetings; been supported in the conducting of clinical trials; or been involved in an advisory capacity by pharmaceutical and biochemical companies. Periodic updates New information arising in areas considered to be of importance will be posted periodically on th